# Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours

> **NCT02853422** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 199 (actual)

## Conditions studied

- Gastrointestinal Neuroendocrine Tumours

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02853422
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02853422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02853422, "Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02853422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*